Syneron Medical Ltd. Sustainability Profile
Syneron Medical Ltd., a prominent player in the aesthetic medical device industry, is headquartered in Israel (IL) and operates globally, with a strong presence in North America, Europe, and Asia. Founded in 2000, the company has established itself as a leader in innovative technologies for non-invasive and minimally invasive aesthetic treatments. Syneron Medical is renowned for its advanced laser and light-based systems, including the popular Candela brand, which offers a range of solutions for hair removal, skin rejuvenation, and body contouring. Their unique combination of proprietary technologies sets them apart in a competitive market, ensuring effective and safe treatments for patients. With a commitment to research and development, Syneron Medical has achieved significant milestones, solidifying its market position and earning recognition for excellence in aesthetic medicine.
DitchCarbon Score
How does Syneron Medical Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Syneron Medical Ltd.'s score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Syneron Medical Ltd.'s reported carbon emissions
Syneron Medical Ltd., headquartered in Israel (IL), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and climate commitments suggests that Syneron Medical Ltd. may not have established formal initiatives to address its carbon footprint or align with industry standards for sustainability. As the company operates within the medical technology sector, it may face increasing pressure to develop and disclose comprehensive climate strategies in line with global efforts to mitigate climate change.
How Carbon Intensive is Syneron Medical Ltd.'s Industry?
How Carbon Intensive is Syneron Medical Ltd.'s Location?
Syneron Medical Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Syneron Medical Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
